Category Archives: ALS Treatment

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (Amylyx or the Company) today announced that Health Canada has approved ALBRIOZA (sodium phenylbutyrate and ursodoxicoltaurine), with conditions, for the treatment of amyotrophic lateral sclerosis (ALS). Continue reading →

Action FDA has approved Radicava ORS (edaravone) oral suspension for the treatment of adults with amyotrophic lateral sclerosis (ALS). Radicava ORS is an orally administered version of Radicava, which was originally approved in 2017 as an intravenous (IV) infusion to treat ALS, commonly referred to as Lou Gehrigs disease Continue reading →

Amyotrophic lateral sclerosis (ALS) is a degenerative disease that affects the brain and spinal cord. ALS causes a loss of voluntary muscle control that worsens over time. This affects movements like talking, swallowing, and walking. Continue reading →

On your back, face down, on the sidewhen youre napping or going to bed for the night, what position do you tend to sleep in? A pre-clinical study suggests how we sleep, especially if its in a lateral position (also known as side-sleeping), can help flush out waste in the brain as we sleep. This waste removal is essential in carrying out brain functions like problem-solving, reasoning and attention to detailalong with keeping your brain healthy Continue reading →

This is a carousel. Use Next and Previous buttons to navigate Lluvia Alzate is competing in the Miss Texas USA pageant to raise awareness for ALS, a neurological disease her mother was diagnosed with in 2019. Lluvia Alzate is competing in the Miss Texas USA pageant to raise awareness for ALS, a neurological disease her mother was diagnosed with in 2019 Continue reading →

John Driskell Hopkins is perfectly in tune. The 51-year-old multi-instrumental musician, who goes by the name "Hop," has played in front of millions of fans across the world as a founding member of the Grammy award-winning group Zac Brown Band Continue reading →

VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (Alpha Cognition, or the Company), a biopharmaceutical company committed to developing novel therapies for people with debilitating neurodegenerative disorders, today announced positive results from its pivotal bioequivalence study with ALPHA-1062, a proprietary, delayed release oral tablet formulation in development for the treatment of mild to moderate Alzheimers Disease (AD) Continue reading →

Amyotrophic lateral sclerosis has affected his face, speech and right arm, but here he was with his wife, Kelsie, and their children -- Cohen, 10, and Willa, 7 -- to present the Norris Trophy and raise awareness of the progressive neuromuscular disease. Snow thumped his chest with his left arm in appreciation. "ALS is an isolating disease," Kelsie told the audience Continue reading →

Last year, Rebecca Andrews made a promise to her dying sons. "I promised them that I would never stop fighting for a cure and treatments until I took my last breath," Andrews said. The boys were the victims of a rare genetic form of ALS, also called Lou Gehrig's disease, which eventually took their lives within a year of each other Continue reading →

PALO ALTO, Calif., Dec. 1, 2021 /PRNewswire/ -- Neuvivo, Inc., a company developing clinical-stage treatments for ALS and other neurodegenerative diseases, today announced its corporate launch, the expansion of its executive team and the creation of its Scientific Advisory Board. Neuvivo's leadcandidate, NP001, has received Orphan Drug and Fast Track designation by the FDA for use in ALS Continue reading →